Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Celularity Inc CELU

Alternate Symbol(s):  CELUW

Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn’s disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and... see more

Bullboard (NDAQ:CELU)

View:
User Avatar Image
(216)
•••
  • coolfooldumbguyX
Post by coolfooldumbguyon Jul 15, 2025 6:39am

Using technical analysis for this stock.

It is signalling a big upswing for shareholders today anyway,so good luck to all
User Avatar Image
(637)
•••
  • IseneschalX
Comment by Iseneschalon Feb 05, 2025 5:57pm

RE:CELU.....Pop goes the weasel

Oops....typo...s/b $2.70 Lo Siento !!!
User Avatar Image
(637)
•••
  • IseneschalX
Post by Iseneschalon Feb 05, 2025 3:50pm

CELU.....Pop goes the weasel

$3.70
User Avatar Image
(637)
•••
  • IseneschalX
Post by Iseneschalon Feb 05, 2025 2:16pm

CELU....on watch @ $2.45

Cheers !
User Avatar Image
(10)
•••
  • MikeTesterX
Post by MikeTesteron Aug 01, 2024 4:13pm

Celularity Inc. (NASDAQ:CELU): Placental-Derived Allogeneic

https://beyondspx.com/2024/08/01/celularity-inc-nasdaqcelu-placental-derived-allogeneic-cell-therapies-and-advanced-biomaterial-products-driving-strong-revenue-growth/